During the past decade, Arnot Ogden Medical Center/Falck Cancer Center conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 37 clinical trials were completed, i.e. on average, 82.2% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 21 clinical trials were completed. i.e. 161.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arnot Ogden Medical Center/Falck Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 33 trials, followed by "National Cancer Institute (NCI)" with 21 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "NRG Oncology" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arnot Ogden Medical Center/Falck Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Arnot Ogden Medical Center/Falck Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (6 trials), "Prostate Cancer" (6 trials) and "Stage IV Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Arnot Ogden Medical Center/Falck Cancer Center" in a lesser frequency.

Most popular intervention types in "Arnot Ogden Medical Center/Falck Cancer Center" are "Drug" (61 trials), "Other" (46 trials), "Biological" (26 trials), "Radiation" (15 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Quality-of-Life Assessment" (16 trials), "Docetaxel" (10 trials), "Biospecimen Collection" (9 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.

The vast majority of trials in "Arnot Ogden Medical Center/Falck Cancer Center" are 58 trials for "All" genders, 10 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Arnot Ogden Medical Center/Falck Cancer Center". undefined are not yet recruiting, 18 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Arnot Ogden Medical Center/Falck Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arnot Ogden Medical Center/Falck Cancer Center, 2 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".